Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2021-11-08 00:00:00 ET · period of report 2021-11-04 · accession 0001209191-21-063386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-08 | 2021-11-04 | PCRX | WINSTON ROY | Chief Medical Off | M - OptEx | $48.15 | +10.0K | 46.5K | +27% | +$481.5K |
| D | 2021-11-08 | 2021-11-04 | PCRX | WINSTON ROY | Chief Medical Off | M - OptEx | $0.00 | -10.0K | 15.0K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | M | A | 10,000 | $48.15 | 46,456 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-11-04 | M | D | 10,000 | $0.00 | 15,000 | D | $48.15 · — to 2027-05-02 | 10,000 Common Stock | (F1) The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years. |